Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 171Terminated 49Recruiting 44Unknown 28Active not recruiting 26Withdrawn 18Not yet recruiting 7Suspended 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2Other solid neoplasm 1Genitourinary 1

Conditions

Small Cell Lung Carcinoma 2Neoplasms 2Lung Neoplasms 2Prostatic Neoplasms 1Mesothelioma 1Glioblastoma 1Esophageal Neoplasms 1Astrocytoma 1

Interventions

Cisplatin 3pembrolizumab 2Etoposide 2Docetaxel 2Carboplatin 2durvalumab 1Specimen Handling 1Radiotherapy 1Radiosurgery 1Radionuclide Imaging 1Radiation 1Prednisone 1Positron-Emission Tomography 1Platinum 1Paclitaxel 1Nivolumab 1Methods 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Injections 1Exercise Therapy 1Erlotinib Hydrochloride 1Eflornithine 1Clinical Protocols 1CTLA-4 Antigen 1Blood Specimen Collection 1Biopsy 1Biological Products 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Lung Neoplasms × Carboplatin × Clear all
NCT05403723 2026-02-19

Adaptive SBRT Plus Chemoimmunotherapy for ES-SCLC

University of Maryland, Baltimore

Phase 1 Suspended
50 enrolled
Thoracic

Lung Neoplasms, Small Cell Lung Carcinoma

NCT01604863 2012-11-01

A Study of HGS1036 in Combination With Chemotherapy in Subjects With Advanced Solid Malignancies

GlaxoSmithKline

Phase 1 Suspended
54 enrolled
GenitourinaryOther solid neoplasmThoracic

Lung Neoplasms, Mesothelioma, Neoplasms, Prostatic Neoplasms, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡